RE: January13 Jan 2026 10:56
Kane
This sounds like we are
From the Abstract
In our ongoing Phase 1 trial of oral GaM for adult patients with recurrent glioblastoma, GaM has been well-tolerated without significant side effects. Thus, we hypothesize GaM can be safely administered enterally to pediatric patients
Also from historic IBAI trials Pediatric trials were mentioned